CH Biotech R&D Co (TPE:6534) Net Change in Cash : NT$-205 Mil (TTM As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is CH Biotech R&D Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

CH Biotech R&D Co's Net Change in Cash for the three months ended in Mar. 2025 was NT$179 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-205 Mil.

CH Biotech R&D Co Net Change in Cash Historical Data

The historical data trend for CH Biotech R&D Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CH Biotech R&D Co Net Change in Cash Chart

CH Biotech R&D Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

42.03

-3.00

209.01

409.91

-461.08

CH Biotech R&D Co Quarterly Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Change in Cash	Get a 7-Day Free Trial															-77.31	-44.51	-242.91	-96.34	178.59

CH Biotech R&D Co Net Change in Cash Calculation

CH Biotech R&D Co's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	538.443	+	-594.767	+	-406.211	+	1.46
	=	-461

CH Biotech R&D Co's Net Change in Cash for the quarter that ended in Mar. 2025

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 208.722 + -42.49 + 11.661 + 0.701

= 179

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-205 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CH Biotech R&D Co Net Change in Cash Related Terms
Thank you for viewing the detailed overview of CH Biotech R&D Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

CH Biotech R&D Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » CH Biotech R&D Co Ltd (TPE:6534) » Definitions » Net Change in Cash

Comparable Companies

TPE:4148 ROCO:6508 TPE:1712 CTVA TSX:NTR DSMD:IQCD CF SAU:2020 SZSE:000792 MOS OSL:YAR BOM:506395 XTAE:ICL BOM:590024 NSE:PIIND NSE:UPL AMM:JOPH SHSE:600096 ADX:FERTIGLB FMC

Traded in Other Exchanges

N/A

Address

No. 89, Wenxian Road, Nantou County, Nantou, TWN, 540001

Website

https://www.chbio.com.tw

CH Biotech R&D Co Ltd is a Taiwan-based company engaged in the manufacture and sales of fertilizer, as well as providing biotechnology services. It is engaged in the research, development, manufacturing, and sales of proprietary plant growth regulators and specialty micronutrient fertilizers. It offers NutriSync 3D plant growers in the form of boron and molybdenum, NutriSync D liquid formulation for dicot crops, CHB-HS for reducing carbon emissions in crop production, CHB-BB2, fruit quality enhancers, and other related products. The company has one reportable segment, Agricultural Biotechnology. Geographically, it derives maximum revenue from the United States, and the rest from other countries.

CH Biotech R&D Co Headlines

No Headlines